GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (OTCPK:PPTDF) » Definitions » Revenue

PPTDF (PeptiDream) Revenue : $311.4 Mil (TTM As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PeptiDream Revenue?

PeptiDream's revenue for the three months ended in Jun. 2024 was $202.1 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $311.4 Mil. PeptiDream's Revenue per Share for the three months ended in Jun. 2024 was $1.56. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $2.40.

Good Sign:

PeptiDream Inc has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of PeptiDream was 77.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 35.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 38.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 40.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 12 years, PeptiDream's highest 3-Year average Revenue per Share Growth Rate was 83.10% per year. The lowest was 14.00% per year. And the median was 36.40% per year.


PeptiDream Revenue Historical Data

The historical data trend for PeptiDream's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PeptiDream Revenue Chart

PeptiDream Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.78 112.50 82.77 199.03 199.42

PeptiDream Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.73 42.84 28.20 202.13 38.27

Competitive Comparison of PeptiDream's Revenue

For the Biotechnology subindustry, PeptiDream's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PeptiDream's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's Revenue distribution charts can be found below:

* The bar in red indicates where PeptiDream's Revenue falls into.



PeptiDream Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $311.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PeptiDream  (OTCPK:PPTDF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


PeptiDream Revenue Related Terms

Thank you for viewing the detailed overview of PeptiDream's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PeptiDream Business Description

Traded in Other Exchanges
Address
1-2-10, Nihonbashi, Chuo-ku, Toyo Building, 6th Floor, Tokyo, JPN, 103-0027
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.